MONROVIA, February 4 (LINA) - Information Minister Lewis Brown has said the current Ebola vaccines trial in the country is an opportunity for Liberia to lead the world in the search for a cure and prevention of the deadly virus.

 
“We must step up to enhance the challenge of finding a preventive cure to the deadly disease, because if we do not, the world would not be able to prevent the virus from recurring,” he said.
 
The World Health Organization findings show that that the disease in most cases re-occurred in countries like Uganda, Congo and Sudan after being declared Ebola free.
 
Speaking at the Information Ministry daily Ebola briefings Wednesday, Brown urged Liberians to welcome the challenge, glue together to prevent the disease and avert the suffering of the citizenry.
 
“Even though your fears of the trial vaccination may be genuine, but we cannot be faulted for not trying to end an epidemic that has the potential of re-occurrence if we do not try our best to fight it totally,” Brown said.
 
Since the vaccines trial started on Monday, February 2, several persons, including members of the Liberian Senate, have expressed concerns over details, protocols, procedures and safety nets put in place by health authorities to ensure a safer environment and renewed outbreak.
 
The vaccine trial is in response to a request from the Health Ministry to the U.S. department of Health and Human Service to form a joint clinical research and partnership to accelerate the development of a vaccine to prevent the virus.
 
The vaccines, the ChAd3-ZEBOV, manufactured by GlaxoSmithKline, a British pharmaceutical company, and the rVSV-ZEBOV, manufactured by Merck/NewLink in Canada, were recognized by a WHO panel at the most advanced stage of development.
LINA